fusion signaling pathway components fgfr (Selleck Chemicals)
Selleck Chemicals is a verified supplier 
Selleck Chemicals manufactures this product 
95
Structured Review
Selleck Chemicals
fusion signaling pathway components fgfr
Fusion Signaling Pathway Components Fgfr, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathway+components/LY2109761/pm37530699-106-8-34
Average 95 stars, based on 176 article reviews
Fusion Signaling Pathway Components Fgfr, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathway+components/LY2109761/pm37530699-106-8-34
Average 95 stars, based on 176 article reviews
fusion signaling pathway components fgfr - by Bioz Stars,
2026-11
95/100 stars
Images
Related Articles
other:Article Title: CD44 knockdown and TGF-β inhibition modulate cell proliferation and invasion in claudin-low breast cancer cells Article Snippet: For the analysis of TGF-β-induced Smad2 phosphorylation, cells were treated with recombinant human TGF-β1 (10 ng/ml; PeproTech, Inc.; Thermo Fisher Scientific, Inc.) at 37°C for 2 h prior to protein extraction, unless otherwise specified. Inhibition:Article Title: SMAD4 loss drives cancer chromosomal instability through transcription-replication conflict-induced replication stress Article Snippet: For inhibition of BMP signaling, cells were treated with 1 μM Type I BMP receptor inhibitor (K02288, Selleckchem, USA). .. Inhibition of the TGFβ receptor I/II was achieved using 0.5–1 μM Concentration Assay:Article Title: Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells Article Snippet: Lymphocyte ablation in Cx3cr1 GFP/+ mice was achieved by administering anti-CD4 (GK1.5, RRID:AB_312687, BioLegend) and anti-CD8 (53-5.8, RRID:AB_2687706, BioXcell) antibodies. .. A selective Cell Culture:Article Title: All-trans retinoic acid modulates proliferation and apoptosis of secondary hair follicle–dermal papilla cells in cashmere goats via the TGF- β 2/Smad2/3 pathway Article Snippet: Cell viability was assessed using the CCK-8 assay based on the WST-8 reagent (Biosharp, Hefei, China). .. SHF-DPCs were seeded into 96-well plates at a density of 5 × 10 3 cells/well in 100 μL of medium and cultured at 37 °C with 5% CO2 for 24 h. After removal of the complete culture medium, cells were washed with PBS and treated with ATRA (HY-14649, MedChemExpress, Monmouth Junction, NJ, United States) at different concentrations (10 −8 , 10 −7 , 10 −6 , 10 −5 , 10 −4 , 10 −3 M) for 24, 48 or 72 h. For mechanistic validation experiments, SHF-DPCs were treated with ATRA (10 −4 M) and/or LY2109761 (2 μM), a Biomarker Discovery:Article Title: All-trans retinoic acid modulates proliferation and apoptosis of secondary hair follicle–dermal papilla cells in cashmere goats via the TGF- β 2/Smad2/3 pathway Article Snippet: Cell viability was assessed using the CCK-8 assay based on the WST-8 reagent (Biosharp, Hefei, China). .. SHF-DPCs were seeded into 96-well plates at a density of 5 × 10 3 cells/well in 100 μL of medium and cultured at 37 °C with 5% CO2 for 24 h. After removal of the complete culture medium, cells were washed with PBS and treated with ATRA (HY-14649, MedChemExpress, Monmouth Junction, NJ, United States) at different concentrations (10 −8 , 10 −7 , 10 −6 , 10 −5 , 10 −4 , 10 −3 M) for 24, 48 or 72 h. For mechanistic validation experiments, SHF-DPCs were treated with ATRA (10 −4 M) and/or LY2109761 (2 μM), a Control:Article Title: All-trans retinoic acid modulates proliferation and apoptosis of secondary hair follicle–dermal papilla cells in cashmere goats via the TGF- β 2/Smad2/3 pathway Article Snippet: Cell viability was assessed using the CCK-8 assay based on the WST-8 reagent (Biosharp, Hefei, China). .. SHF-DPCs were seeded into 96-well plates at a density of 5 × 10 3 cells/well in 100 μL of medium and cultured at 37 °C with 5% CO2 for 24 h. After removal of the complete culture medium, cells were washed with PBS and treated with ATRA (HY-14649, MedChemExpress, Monmouth Junction, NJ, United States) at different concentrations (10 −8 , 10 −7 , 10 −6 , 10 −5 , 10 −4 , 10 −3 M) for 24, 48 or 72 h. For mechanistic validation experiments, SHF-DPCs were treated with ATRA (10 −4 M) and/or LY2109761 (2 μM), a |